Advertisement
Screener

BioCardia, Inc. (BCDA) Increase (Decrease) in Other Receivables

2.8 / 5 stars · 68/120 Roast Me

BioCardia, Inc. Increase (Decrease) in Other Receivables

BioCardia, Inc. (BCDA) reported Increase (Decrease) in Other Receivables of $0 for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-08.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2012-11-08

  • BioCardia, Inc. increase (decrease) in other receivables for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
  • BioCardia, Inc. increase (decrease) in other receivables for the quarter ending 2011-09-30 was $171.00K.
  • BioCardia, Inc. increase (decrease) in other receivables for the quarter ending 2010-09-30 was $0.00.
Period endIncrease (Decrease) in Other Receivables 3 monthIncrease (Decrease) in Other Receivables 6 monthIncrease (Decrease) in Other Receivables 9 month
2012-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
$0.00
10-Q · filed 2012-11-08
2012-06-30$0.00
10-Q · filed 2012-08-10
2011-09-30$171.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
-$22.00K
10-Q · filed 2012-11-08
2011-06-30-$193.00K
10-Q · filed 2012-08-10
2010-09-30$0.00
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-15
$0.00
10-Q · filed 2011-11-15
2010-06-30$0.00
10-Q/A · filed 2011-11-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
Passage BIO, Inc. (PASG)United States$0.015B-0.43
Pluri Inc. (PLUR)$0.014B
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
IN8BIO, INC. (INAB)United States$0.012B-0.76
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23